hERG Channel Physiology and Drug‐Binding Structure–Activity Relationships
Sarah Dalibalta, John S. Mitcheson
Abstract
Sarah Dalibalta, John S. Mitcheson
Abstract
This chapter contains sections titled: Introduction hERG Channel Structure hERG Potassium Channels and the Cardiac Action Potential Mutations in hERG Are Associated with Cardiac Arrhythmias Acquired Long QT Syndrome Drug-Binding Site of hERG Structural Basis for hERG Block Alternative Mechanisms of Block Role of Inactivation in hERG Block Inhibition of hERG Trafficking by Pharmacological Agents Computational Approaches to Predict hERG K+ Channel Block Conclusions References
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter contains sections titled: Introduction hERG Channel Structure hERG Potassium Channels and the Cardiac Action Potential Mutations in hERG Are Associated with Cardiac Arrhythmias Acquired Long QT Syndrome Drug-Binding Site of hERG Structural Basis for hERG Block Alternative Mechanisms of Block Role of Inactivation in hERG Block Inhibition of hERG Trafficking by Pharmacological Agents Computational Approaches to Predict hERG K+ Channel Block Conclusions References
Key concepts: hERG, Long QT syndrome, Potassium channel, Pharmacology, Block (permutation group theory), Cardiac action potential, Drug, Chemistry